The company shall submit to USFDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection, the drug firm said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35EWPWG
via IFTTT
0 comments:
Post a Comment